Overview of technology and key success factors for CDx

Developing and Commercializing Companion Diagnostics

Aruna Rajan, Michael Jacobson, Kerry Xie and Harry Glorikian, are featured in the September/October, 2011 issue of European Medical Device Technology (EMDT) with an article titled: "Developing and Commercializing Companion Diagnostics"

Companion diagnostics (CDx) --tests used to ensure that prescribed drugs will be safe and effective for particular patients-- have been hailed as driving an impending revolution in medicine. However, most CDx developers must overcome a variety of hurdles if they are to achieve developmental and commercial success in a complex and rapidly changing medical landscape.

In this article, we provide an overview of major current and next-generation CDx and consider the technological requirements for their successful development and commercialization.

The article can be accessed on the EMDT website here.

SCIENTIA ADVISORS, LLC | info@scientiaadv.com

55 Cambridge Parkway, Suite 300E, Cambridge MA 02142 | Phone: 617-299-3000 | Fax: 617-812-0315